NCT00060138View on ClinicalTrials.gov

Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2002

Primary Completion Date

September 30, 2004

Conditions
Breast CancerHypercalcemia of MalignancyMetastatic CancerPain
Interventions
BIOLOGICAL

monoclonal antibody CAL

DRUG

zoledronic acid

Trial Locations (1)

44106-5065

Ireland Cancer Center, Cleveland

Sponsors
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Chugai Pharmaceutical

INDUSTRY